Biotech Stock Alert; (OTC: AEMD) Trading Up 21% on News of Availability of its Exosome Detection Assay

Point Roberts, WA- October 18 , 2011- Investorideas.com , an investor research portal specializing in sector research including biotech and pharma stocks, report Aethlon Medical (OTCBB: AEMD), a pioneer in developing therapeutic filtration devices is trading up at 0.08, up 0.0140 (21.21%) in late morning trading on over 450,000 shares.

The Company reported news on the opening that it will begin accepting orders for its Enzyme Linked Lectin Specific Assay (ELLSA™) from researchers that require a highly sensitive diagnostic tool to detect the  presence of exosomes in cell culture, ascites, and other biological fluids, including blood.



Biotech Investor Snapshot for Aethlon Medical (OTCBB: AEMD)
The Aethlon Medical mission is to create innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer; HER2osome™ to target HER2+ breast cancer, and a medical device being developed under a contract with the Defense Advanced Research Projects Agency (DARPA) that would reduce the incidence of sepsis in combat-injured soldiers and civilians. For more information, please visit www.aethlonmedical.com.

Visit the AEMD showcase page on Investorideas.com
http://www.investorideas.com/CO/AEMD

Get biotech news and stock alerts  
http://www.investorideas.com/Resources/Newsletter.asp

Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp

About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. AETHLON MEDICAL INC(OTC BB: AEMD ) Showcase biotech,  biodefense and defense stock on Investorideas.com ( $one thousand five hundred per month, $five thousand per month in 144 stock)Effective March 15, 2011       
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source – www.Investorideas.com



 

Trending Investor Searches; (NASDAQ:BPAX), (NASDAQ:HEV), (NASDAQ:AONE), (NASDAQ:SZYM) Make Top Four 

Water Stocks, Natural Gas Stocks and Renewable Energy Stocks Lead Sectors  

POINT ROBERTS, October 18 ,  2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on this weeks trending top ten investor searches.

BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX ) was the most searched by investors in the past week following news from the Company that the independent Data Monitoring Committee (DMC) had completed the seventh unblinded review of the LibiGel Phase III cardiovascular and breast cancer safety study, which has completed enrollment of subjects. The independent DMC has recommended that the LibiGel safety study should continue as per the FDA-agreed protocol, without modifications. LibiGel (testosterone gel) is in development for the treatment of female sexual dysfunction (FSD), specifically, hypoactive sexual desire disorder (HSDD) in menopausal women, for which there is no FDA-approved product.

Leading sectors searched by investors included water stocks, natural gas stocks and renewable energy stocks.


Investorideas.com Top Investor Searches…

1. NASDAQ:BPAX  
2. NASDAQ:HEV
3. NASDAQ:AONE
4. NASDAQ:SZYM
5. NASDAQ:TSLA
6. Water Stocks    
7. NASDAQ:SINA
8. NASDAQ:TQNT
9. Natural Gas Stocks  
10. Renewable Energy Stocks

About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook   http://www.facebook.com/Investorideas

Investorideas.com Free Investor Tools;
Learn More about Investorideas.com showcase stocks
http://www.investorideas.com/Showcase/

Sign up for the free investor news and stock alerts- water stocks, renewable energy, gold stocks and more
http://www.investorideas.com/Resources/Newsletter.asp

Join Investor Ideas – Become a Member
Research renewable energy stocks, gold stocks, water stocks, oil and gas and more with the largest stock directories online for investors
Investorideas.com Members currently have 24/7 online access to the  exclusive subscriber-only 13 stock directories in leading sectors including renewable energy, water and energy stocks. The renewable energy stocks directory features over 1300 green stocks, making it the largest online !   
Visit the Investor Ideas membership page to learn more at:
http://www.investorideas.com/membership/

Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. BPAX is a paid showcase stock on Investorideas.com – six thousand five hundred for 3 months
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Source – Investorideas.com
800-665-0411

Monday's NASDAQ Winners: ANDS, BEXP, SNDA, RMTR

POINT ROBERTS - October 18, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Monday October 17th. Markets were off once again on Euro woes with Nasdaq closing lower by -52.93 (-1.98%) at 2614.92.

Yes Virginia there is a Santa Clause... Anadys Pharmaceuticals, Inc. (NASDAQ:ANDS) was the top percentage gainer for the session closing higher 2.61, a whopping (250.96%) to $3.65 after the company reported it agreed to be acquired by Roche Holding AG for $3.70 a share. Anadys' board has recommended stockholders tender their shares and, if necessary, adopt the merger agreement. This news was of course followed by the usual barrage of law firm announcements questioning the deal for shareholders.
The stock is continuing its gains in morning trading for Tuesday's session.
Brigham Exploration Company (NASDAQ:BEXP) surged 6.39 (21.05%) to close at $6.75 after Statoil ASA said that it has agreed to buy the company for $4.4 billion.
Shana Interactive Entertainment Ltd ADR (NASDAQ:SNDA) closed with an impressive gain of 4.85 (14.49%) to end the day at $38.33 after Chairman Chen Tianqiao said he would buy all outstanding shares to take the company private.
Ramtron International (NASDAQ:RMTR) moved higher by 0.23 (11.68%) to $2.20, bouncing back from its recent low of $1.95. The stock has a 52-week range of $1.87-$4.17. The company has market capitalization of $63.48 million.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Investor Research Tools;
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas: stock directories and trading alerts, investing ideas
Get 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more
Join: http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411
Source - www.Investorideas.com

Biotech Stock News; Aethlon Medical (OTCBB: AEMD) Announces Availability of its Exosome Detection Assay to the Research Community

SAN DIEGO � October 18, 2011 (Investorideas.com newswire) - Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it will begin accepting orders for its Enzyme Linked Lectin Specific Assay (ELLSA™) from researchers that require a highly sensitive diagnostic tool to detect the presence of exosomes in cell culture, ascites, and other biological fluids, including blood.

"We are going to produce ELLSA™ on a limited basis to satisfy the organic demand for our technology, which is primarily being driven by researchers who participated in a beta-testing program," stated Aethlon CEO, Jim Joyce. "However, as our focus is directed toward advancing Aethlon ADAPT™ system therapies, we plan to license or sell ELLSA™ to an organization that is already established in the research diagnostics field." Each ELLSA™ plate allows for up to 96 exosome detection tests. Further analysis of the captured exosomes is possible through detection molecules such as antibodies linked to a specific biomarker on the exosome. ELLSA™ has demonstrated the ability to identify and quantify the presence of exosomes produced by human immunodeficiency virus (HIV), and tuberculosis (TB), as well as all forms of cancer tested to date. The introductory price for each ELLSA order placed by November 30, 2011 is $179.00 per kit. To place an order, contact Paul Duffin at 858-459-7800 x306, or by email at paul@aethlonmedical.com. Aethlon Medical is offering ELLSA™ for research purposes only and not for human use.
About Aethlon Medical
The Aethlon Medical mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. The Aethlon ADAPT™ system is an expansive technology platform that converges affinity drug agents and plasma membrane technology to create therapeutic filtration devices that selectively target the removal of harmful particles from the entire circulatory system. Our lead therapeutic candidate is the Aethlon Hemopurifier®, a device with broad-spectrum capabilities against viral pathogens and immunosuppressive cancer exosomes. In human studies, Hemopurifier® therapy has provided significant viral load reductions in HIV and hepatitis C virus infected individuals without the administration of antiviral drugs. We are now focused on advancing our Hemopurifier® as an adjunct strategy to improve the benefit of established infectious disease and cancer treatment regimens. Based on studies conducted by government and non-government research organizations, the Hemopurifier® is also a leading broad-spectrum treatment candidate to address bioterror and pandemic threats. For more information, please visit www.aethlonmedical.com.
Certain of the statements herein may be forward-looking and involve risks and uncertainties. Such forward-looking statements involve assumptions, known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Aethlon Medical, Inc. to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such potential risks and uncertainties include, without limitation, the ability to demonstrate ex vivo effectiveness of the Aethlon Hemopurifier® to remove immunosuppressive exosomes from the blood of advanced-stage cancer patients, future therapeutic trials in cancer patients, future human studies of the Aethlon Hemopurifier® as an adjunct therapy to improve patient responsiveness to established cancer therapies, the Hemopurifier's® ability to capture exosomes and the impact it may have on disease conditions, the Company's ability to raise capital when needed, the Company's ability to complete the development of its planned products, the ability of the Company to obtain FDA and other regulatory approvals permitting the sale of its products, the Company's ability to manufacture its products either internally or through outside companies and provide its services, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.
Contacts:
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com
Jody Cain
Senior Vice President, Lippert/Heilshorn & Associates
310.691.7100
jcain@lhai.com
Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com
John P. Salvador
Director, Communications & Investor Relations
858.459.7800 x307
jps@aethlonmedical.com

AETHLON MEDICAL INC (OTC BB: AEMD) is a Showcase biotech, biodefense and defense stock on Investorideas.com
Visit the AETHLON MEDICAL INC (OTC BB: AEMD) showcase profile page

Disclosure/Disclaimer: AETHLON MEDICAL INC (OTC BB: AEMD) is a paid advertising client ($one thousand five hundred per month, $five thousand per month in 144 stock)

Water/ Infrastructure Stock Alert: Pure Technologies Ltd. (TSX: PUR) Trading Up Over 16%

POINT ROBERTS - www.InvestorIdeas.com, a leader in sector stock research including water stocks and infrastructure stocks issues a trading alert for Pure Technologies Ltd.(TSX:PUR). The stock is trading at $3.45, up 0.49 (16.55%).
In September the Company announced it had been awarded new contracts in the United States for a combined value of approximately US$2 million. The services provided with these projects span the full range of Pure's inspection, condition assessment and engineering services for water and wastewater pipelines.
About Pure Technologies ( TSX: PUR)

Pure Technologies Ltd. is an international asset management technology and services company which has developed patented technologies for inspection, monitoring and management of critical infrastructure around the world. Pure's business model incorporates four distinct but complementary business streams:

• Sales of proprietary monitoring technologies for pipelines, bridges and structures (SoundPrint®, SoundPrint® AFO);
• Recurring revenue from data analysis and site maintenance for these technologies, and from technology licensing;
• Premium technical services including inspection, leak detection and condition assessment (P-Wave®, SmartBall®, Sahara®, PipeDiver™, PureRobotics™);
• Specialized engineering services in areas related to asset management, primarily in the area of pipeline condition assessment for water and wastewater infrastructure (Openaka Corp., Price Brothers UK Ltd, and Jason Consultants).

Investor Ideas Showcase Infrastructure Stock
Visit the company Profile on Investorideas.com
http://www.investorideas.com/CO/FRCN/
About Fireman's Contractors Inc. (OTCBB: FRCN)
Fireman's Contractors Inc. (OTCBB: FRCN) is a full service contractor providing superior service in parking lot maintenance and construction services. Our services include Road Improvements, Seal Coating, Parking Lot Striping, Pavement Marking, Asphalt Maintenance and Repair, ADA Compliance and other construction services which are delivered at a competitive price. Fireman's brings professional value system delivering outstanding results through honorable customer relationships and repeat business. Local firefighters are supported by a portion of profits which are donated to local Firefighter Associations. http://www.firemans-contractors.com/
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising .
Disclosure: Fireman's Contractors Inc. (OTCBB: FRCN) is a paid adverting construction stock on Investorideas.com and blogs (ten thousand for 3 months of advertising)
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Investorideas.com was not compensated by PUR.TO
Source - Investorideas.com
800-665-0411

Infrastructure/ Construction Stock News: Fireman's Contractors (OTCBB:FRCN) Moves to New Texas Location to Facilitate Expansion and Growth

FORT WORTH, Texas - October 17, 2011 - Construction Stock News update: Fireman's Contractors Inc. (OTCBB: FRCN) (OTCQB:FRCN.OB) reports it has moved into their new corporate offices in Fort Worth , Texas . The relocation from North Richland Hills was spurred by continuous growth within the Company, including customer service, marketing, sales, operational personnel and will allow it to begin new efforts in franchise development. The Company is a full service contractor providing professional services for commercial and government clients in Road Improvements, Parking Lot Maintenance, Seal Coating, Parking Lot Striping, Pavement Marking, and Asphalt Maintenance and Repair.

"We are excited to complete renovations and move into a national corporate space where we can accommodate our growth, expand our services, cultivate our business relationships, develop our franchise system, and enable current and future employees to work efficiently under one roof," stated, Renee Gilmore, CEO of Fireman's Contractors.
New Headquarters: Fireman's Contractors, Inc.
2406 Gravel Drive
Fort Worth , TX 76118
Fireman's Contractors Inc. (OTCBB:FRCN.OB) is a full service contractor providing professional services for commercial and government clients. Services include Road Improvements, Parking Lot Maintenance, Seal Coating, Parking Lot Striping, Pavement Marking, Asphalt Maintenance and Repair, and ADA Compliance. Fireman's Contractors has completed its FDD requirements with the Federal Trade Commission and has developed franchise territories across the U.S. The Company's goal is to develop 25 new franchise locations in the next 24 to 48 months. Fireman's brings a professional value system delivering outstanding results through honorable customer relationships and repeat business. Local firefighters are supported by a portion of profits which are donated to local Firefighter Associations.
Founded by a Firefighter, Fireman's Contractors -- Contractors You Can Trust (R)
To learn more about Fireman's Contractors, please visit our website:
http://www.Firemans-Contractors.com
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate assumptions, and are subject to various business risks and known and unknown uncertainties, a number of which are beyond the control of management. Therefore, actual results could differ materially from the forward-looking statements contained in this press release. Additional information respecting the factors that could materially affect the Company and its operations are contained in its annual report on Form 10K and Form 10-Q as filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statement.
Contact:
Fireman's Contractors Inc.
2406 Gravel Road
Fort Worth , TX 76118
Phone: 800-475-1479
info@FiremansContractors.com
http://www.Firemans-Contractors.com
Investor Relations Contact:John Pentony, IR Affiliates
Contact: john@iraffiliates.com
Tel: 469.252.3031
Public Relations Contact: Danielle O'Neal
Contact: PR@FiremansContractors.com
Tel: 800-475-1479
Follow FIREMANS CONTRACTORS, Inc. (OTCBB:FRCN) on Twitter.com
http://twitter.com/#!/firemansco
Follow FIREMANS CONTRACTORS, Inc. (OTCBB:FRCN) on Facebook.com
http://www.facebook.com/FiremansContractors

Fireman's Contractors Inc. (OTCBB:FRCN), (OTCQB:FRCN.OB) is a featured construction stock on Investorideas.com

Visit the company profile to learn more: http://www.investorideas.com/CO/FRCN/

Disclaimer/ Disclosure: FRCN has compensated Investorideas.com ten thousand for three months of advertising. All info published is sourced from public files or the Company. This is not a solicitation go buy or sell securities.

Biotech Leads Friday's NASDAQ Winners: GTXI, ACHN, SZYM, GNOM;

POINT ROBERTS - October 17, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Friday October 14th. Nasdaq closed higher by +47.61 (+1.82%) at 2667.85.

GTx, Inc. (NASDAQ:GTXI) was the top percentage gainer for the session closing higher 0.68 (20.36%) to $4.02 after analyst at Rodman & Renshaw started coverage on the stock an "outperform" rating and a $7.00 price target on the stock.
The stock is continuing its gains in early morning trading Monday.
The Company is a biopharmaceutical company dedicated to the discovery, development, and commercialization of small molecules that selectively target hormone pathways for the treatment of cancer, cancer supportive care, and other serious medical conditions.
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) surged 0.89 (18.05%) to close at $5.82 after it announced the nomination of an additional clinical candidate for the treatment of the hepatitis C virus (HCV) from its NS5A inhibitor program. The candidate, ACH-3102, is a second generation NS5A inhibitor that in preclinical studies has demonstrated potent pan-genotypic activity against HCV genotypes 1 - 6, including excellent activity against both the genotype 1a subtype and known mutant variants of genotype 1 HCV.
Solazyme Inc (NASDAQ:SZYM) closed with an impressive gain of 1.50 (17.99%) to end the day at $9.84, bouncing back from its recent low. The stock has a 52-week range of $7.68-$27.47. The company has market capitalization of $587.15 million.
Complete Genomics, Inc. (NASDAQ:GNOM) moved higher by 0.78 (16.53%) to $5.50, bouncing back from its 52-week low made on Oct 13, 2011. The stock has a 52-week range of $4.70-$18.55. The company has market capitalization of $181.99 million.
About www.InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Investor Ideas Investor Research Tools;
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 13 of the best stock directories online plus stock alerts and investing ideas
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more
Join monthly or annually: http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411
Source - www.Investorideas.com

Biotech and Pharma stocks News; BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) To Present at BioCentury and BIO Healthcare Conferences

LINCOLNSHIRE, Ill. - October 17, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) today announced that Stephen M. Simes, BioSante�s president & CEO will present at two healthcare conferences in October. Mr. Simes will speak at the BioCentury NewsMakers in the Biotech Industry on Friday, October 21 at 11:30 am EDT in New York and at the BIO Investor Forum on Tuesday, October 25 at 3:30 pm PDT in San Francisco.

BioSante will provide a company overview at each conference, as well as an update on the LibiGel� (testosterone gel) Phase III clinical development program and planned new drug application (NDA) submission.
A live audio webcast of remarks by Mr. Simes, at the BioCentury conference may be accessed at http://www.corporate-ir.net/ireye/ conflobby.zhtml?ticker= BPAX&item_id=4209619. A live audio webcast of remarks by Mr. Simes, at BIO Investor Forum may be accessed at http://www.veracast.com/webcasts/ bio/ investorforum2011/16113461.cfm. Both webcasts will be archived for 90 days.
About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD) which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) Special Protocol Assessment. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other products in development are Bio-T-Gel™, a testosterone gel for male hypogonadism licensed to Teva Pharmaceuticals and an oral contraceptive in Phase II clinical development using BioSante patented technology. The company also is seeking opportunities for its other technologies. Additional information is available online at: www.biosantepharma.com.
Contact:
BioSante Pharmaceuticals
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
or
For Media:
Harris D. McKinney, Inc.
Alan Zachary, 312-506-5220
azachary@harrisdmckinney.com
BioSante Pharmaceuticals, Inc: (NASDAQ: BPAX) is a featured showcase biotech/pharma stock on Investorideas.com
Request news, updates and trading alerts on BPAX and other showcase stocks http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including biotech and pharma stocks.
Disclaimer: The following news/content is paid for as part of the BPAX showcase program (two thousand per month) Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp  
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp  
Source: Investorideas.com, BioSante, Investorideas.com
800 665 0411 cvanzant@investorideas.com

Nanotech Stock to Watch; Nanosphere, Inc. (NasdaqGM: NSPH) Trading up over 8%

POINT ROBERTS, October 14, 2011 - Investorideas.com, a leader in sector research for independent investors issues a trading alert for nanotech stock, Nanosphere, Inc.(NasdaqGM: NSPH), trading at $1.12, up 0.09 (8.25%) 3:17PM EDT.
The most recent news from the Company, September 19th, stated "Nanosphere's (Nasdaq:NSPH) Verigene BC-GP test, based on the company's proprietary array-based nanoparticle technology, demonstrated 100% sensitivity and specificity for detection of the drug-resistant bacteria MRSA and VRE, and an overall sensitivity of 98.4% for a broad panel of bacterial targets, according to an initial study."
Nanosphere is using the power of nanotechnology to create innovative molecular diagnostics for the medical field. The Verigene(R) System is an easy-to-use cartridge-based platform that enables rapid, cost-effective, multiplexed testing in a near-patient setting. Current and forthcoming products include clinical diagnostics in the areas of infectious disease, pharmacogenetics, cardiology, and human genetics.

About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Learn More about Investorideas.com Nanotech showcase stocks
http://www.investorideas.com/Nanotechnology/
Get the global stock directory of publicly traded nanotech stocks
http://www.investorideas.com/Nanotechnology/ Stocks_List.asp
Sign up for the free investor news and hot stock alerts http://www.investorideas.com/ Resources/Newsletter.asp
Join Investor Ideas - Become a Member
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only 13 stock directories in leading sectors including nanotech, renewable energy, water and energy stocks. Get stock alerts and hot news!
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising .
Investorideas.com was not compensated by Nanosphere for this article
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source - Investorideas.com
800-665-0411

Skilled Trades people Shortage Could Lead to Opportunity for Fireman's Contractors Inc. (OTCBB: FRCN)

POINT ROBERTS, - www.InvestorIdeas.com, a leader in sector stock research including construction stocks, homebuilder and infrastructure stocks releases the following commentary on the sector and Fireman's Contractors Inc. (OTCBB: FRCN).

Headlines across Canada and the US remind us that the attention that shifted from trade to higher education has caught us with a shortage of skilled trade’s people.

In Northern Ontario and Alberta where unemployment rates are low, there is a high demand and a serious shortage of skilled labor. So much so, that Canada is encouraging unemployed US workers to come to Canada.

According to a recent article in  Daily Commercial news, “Trades training has long since been removed from the high school curriculum and it’s having an impact now.”

In the US, there is an obvious gap in the demand for skilled labour and the high unemployment numbers.

Contractors and small constructions companies can fill some of the gaps in the interim. Fireman's Contractors Inc. (OTCBB: FRCN) focuses on road improvement, seal coatings, parking lots and other construction services.

According to the company:

7 Reasons Why Our Customers Choose Fireman's Contractors:

Attention to Details
We strive to be the best at what we do. Our crews are trained to pay attention to every detail on the job site to provide you with the best service possible.
Professional Service
We provide on time, uniformed, professional crews on every job site.
Quality Service and Products
While many other Contractors may use lower quality products, we strive to offer the highest quality products and back it up with a one year warranty.
Warranty
We offer a one year warranty on our parking lot maintenance workmanship.
Insured
We carry $1 Million per occurrence, $2 Million aggregate liability policy and a 500/500/500 workman's compensation policy.
Value
It is our goal to provide the most competitive prices in the marketplace without compromising quality, service or our integrity.
Contractors You Can Trust ®
It's not only our slogan, it's our creed. We strive to provide services with the same values, principles and excellence based on the Firefighter's Code of Honor.
    

Showcase Infrastructure Stock
Visit the company Profile on Investorideas.com
http://www.investorideas.com/CO/FRCN/

About Fireman's Contractors Inc. (OTCBB: FRCN)
Fireman's Contractors Inc. (OTCBB: FRCN) is a full service contractor providing superior service in parking lot maintenance and construction services. Our services include Road Improvements, Seal Coating, Parking Lot Striping, Pavement Marking, Asphalt Maintenance and Repair, ADA Compliance and other construction services which are delivered at a competitive price. Fireman's brings professional value system delivering outstanding results through honorable customer relationships and repeat business. Local firefighters are supported by a portion of profits which are donated to local Firefighter Associations. http://www.firemans-contractors.com/

Follow FIREMANS CONTRACTORS, Inc. (OTCBB: FRCN) on Twitter.com
http://twitter.com/#!/firemansco

Follow FIREMANS CONTRACTORS, Inc. (OTCBB: FRCN) on Facebook.com
http://www.facebook.com/FiremansContractors

IR Contact info:
Tel: 1(214) 314-1588
Email: invest@fireamscontractors.com

About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook   http://www.facebook.com/Investorideas

Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising.
Disclosure: Fireman's Contractors Inc. (OTCBB: FRCN) is a paid adverting construction stock on Investorideas.com and blogs (ten thousand for 3 months of advertising)
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source – Investorideas.com

800-665-0411

Investors Ride the Wave for Ocean Power Technologies (Nasdaq:OPTT); Stock Trades Up Over 12%  


Point Roberts WA-, October14, 2011 (Investorideas.com renewable energy/green newswire) Investorideas.com, a leader in renewable energy stock research, releases a trading alert for wave technology stock Ocean Power Technologies, Inc. (Nasdaq:OPTT)  The stock is one of the top percentage gainers on NASDAQ, trading at $4.25, up  0.47 (12.43%) 12:03PM EDT.


AP reported a story on Ocean Power Technologies yesterday that” Environmental regulators in Oregon are proposing approval of a New Jersey company's plan to put 10 wave energy buoys off the central coast.”




Ocean Power Technologies, Inc. (Nasdaq:OPTT) is a pioneer in wave energy technology that harnesses ocean wave resources to generate reliable, clean and environmentally-beneficial electricity. OPT has a strong track record in the advancement of wave energy, and participates in an estimated $150 billion annual power generation equipment market. OPT’s proprietary PowerBuoy® system is based on modular, ocean-going buoys that capture and convert predictable wave energy into clean electricity. The Company is widely recognized as a leading developer of on-grid and autonomous wave energy generation systems, benefiting from 15 years of in-ocean experience. OPT is headquartered in Pennington, New Jersey with an office in Warwick, UK. More information can be found at www.oceanpowertechnologies.com.

Research over 1300 other green stocks on global stock exchanges with Investor Ideas stock directory

About Investorideas.com – a leader in cleantech investor research
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.

Join Investor Ideas – Become a Member
Get login access to 13 stock directories including the Renewable Energy stocks directory, water stocks directory,  plus hot news and stock alerts, directories updated each month  
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/

Visit Investorideas.com green and renewable showcase stocks and more investor research in the sector: http://www.investorideas.com/Companies/RenewableEnergy/  or
www.renewableenergystocks.com

Investors - sign up for free green stocks trading alerts and news
http://www.investorideas.com/Resources/Newsletter.asp

Follow Renewable Energy Stocks on Facebook.com
http://www.facebook.com/renewableenergystocks

Disclaimer/ Disclosure: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Investorideas.com is not compensated by AONE

For more information about Investorideas.com contact:
800.665.0411